156 related articles for article (PubMed ID: 18974129)
1. Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.
Park JT; Shih IeM; Wang TL
Cancer Res; 2008 Nov; 68(21):8852-60. PubMed ID: 18974129
[TBL] [Abstract][Full Text] [Related]
2. Defining NOTCH3 target genes in ovarian cancer.
Chen X; Thiaville MM; Chen L; Stoeck A; Xuan J; Gao M; Shih IeM; Wang TL
Cancer Res; 2012 May; 72(9):2294-303. PubMed ID: 22396495
[TBL] [Abstract][Full Text] [Related]
3. Notch3 gene amplification in ovarian cancer.
Park JT; Li M; Nakayama K; Mao TL; Davidson B; Zhang Z; Kurman RJ; Eberhart CG; Shih IeM; Wang TL
Cancer Res; 2006 Jun; 66(12):6312-8. PubMed ID: 16778208
[TBL] [Abstract][Full Text] [Related]
4. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing.
Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Talora C; Frati L; Gulino A; Screpanti I
EMBO J; 2007 Mar; 26(6):1670-80. PubMed ID: 17332745
[TBL] [Abstract][Full Text] [Related]
5. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
6. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites.
Thiaville MM; Stoeck A; Chen L; Wu RC; Magnani L; Oidtman J; Shih IeM; Lupien M; Wang TL
PLoS One; 2012; 7(5):e36054. PubMed ID: 22567123
[TBL] [Abstract][Full Text] [Related]
7. Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama S; Otsuki Y; Miyazaki K
Am J Clin Pathol; 2012 Oct; 138(4):535-44. PubMed ID: 23010708
[TBL] [Abstract][Full Text] [Related]
8. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
9. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
10. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
11. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
12. PBX1 and MEIS1 up-regulate SOX3 gene expression by direct interaction with a consensus binding site within the basal promoter region.
Mojsin M; Stevanovic M
Biochem J; 2009 Dec; 425(1):107-16. PubMed ID: 19799567
[TBL] [Abstract][Full Text] [Related]
13. The PBX1 lupus susceptibility gene regulates CD44 expression.
Niu Y; Sengupta M; Titov AA; Choi SC; Morel L
Mol Immunol; 2017 May; 85():148-154. PubMed ID: 28257976
[TBL] [Abstract][Full Text] [Related]
14. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract][Full Text] [Related]
15. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
[TBL] [Abstract][Full Text] [Related]
16. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
Gramantieri L; Giovannini C; Lanzi A; Chieco P; Ravaioli M; Venturi A; Grazi GL; Bolondi L
Liver Int; 2007 Sep; 27(7):997-1007. PubMed ID: 17696940
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Notch3 Using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells.
Xiang J; Ouyang Y; Cui Y; Lin F; Ren J; Long M; Chen X; Wei J; Zhang H
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):59-65. PubMed ID: 21940234
[TBL] [Abstract][Full Text] [Related]
19. Functional redundancy of the Notch gene family during mouse embryogenesis: analysis of Notch gene expression in Notch3-deficient mice.
Kitamoto T; Takahashi K; Takimoto H; Tomizuka K; Hayasaka M; Tabira T; Hanaoka K
Biochem Biophys Res Commun; 2005 Jun; 331(4):1154-62. PubMed ID: 15882997
[TBL] [Abstract][Full Text] [Related]
20. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk.
Peters N; Opherk C; Zacherle S; Capell A; Gempel P; Dichgans M
Exp Cell Res; 2004 Oct; 299(2):454-64. PubMed ID: 15350543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
